Edwards Lifesciences Corp (EW)
About Edwards Lifesciences Corp
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $6.1B
- Net income
- $1.1B
- Total assets
- $13.7B
- Market cap
- $47.6B
- Gross margin
- 78.0%
- Operating margin
- 20.8%
- Net margin
- 17.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $6.1B
- Cost of revenue
- $1.3B
- Gross profit
- $4.7B
- Operating expenses
- $3.5B
- Operating income
- $1.3B
- Income tax
- $216.9M
- Net income
- $1.1B
- EPS (basic)
- $1.84
- EPS (diluted)
- $1.83
Balance sheet
- Total assets
- $13.7B
- Current assets
- $6.7B
- Total liabilities
- $3.4B
- Current liabilities
- $1.8B
- Shareholders’ equity
- $10.3B
Cash flow
- Operating cash flow
- $1.6B
- Investing cash flow
- -$712.9M
- Financing cash flow
- -$956.8M
- Net cash flow
- -$119.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $47.6B
- P/E ratio
- 45.2
- EPS (diluted)
- $1.83
- Shares outstanding
- 599.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 3, 2000
Edwards Lifesciences Corp (EW) Stock Price
- Profitable — net income of $1.1B in FY2025.
- Revenue grew 38% from FY2020 to FY2025.
- Gross margin of 78.0%, net margin 17.6%.
- Trading 13% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 45.2.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Edwards Lifesciences Corp.
Write a review
News about Edwards Lifesciences Corp
News & sentiment via Polygon.io
Edwards Lifesciences Corp: frequently asked questions
Is Edwards Lifesciences Corp an American company?
Yes — Edwards Lifesciences Corp is an American company headquartered in Irvine, California. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Edwards Lifesciences Corp headquartered?
Edwards Lifesciences Corp is headquartered in Irvine, California, United States.
Is Edwards Lifesciences Corp publicly traded?
Yes — Edwards Lifesciences Corp is a publicly traded company. Its stock trades under the ticker symbol EW on the NYSE.
What does Edwards Lifesciences Corp do?
Edwards Lifesciences Corp is an American Medical Devices company in the Health & Beauty sector.
